Bioavailability assessment: Methods to estimate total area (AUC 0-∞) and total amount excreted (A e ∞ ) and importance of blood and urine sampling scheme with application to digoxin
- 1 October 1977
- journal article
- research article
- Published by Springer Nature in Journal of Pharmacokinetics and Biopharmaceutics
- Vol. 5 (5) , 533-557
- https://doi.org/10.1007/bf01061733
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- Pharmacokinetic parameters estimated from intravenous data by uniform methods and some of their usesJournal of Pharmacokinetics and Biopharmaceutics, 1977
- Orthogonal least squaresJournal of Pharmaceutical Sciences, 1976
- Biased Bioavailability EstimatesJournal of Pharmaceutical Sciences, 1976
- Bioavailability of DrugsClinical Pharmacokinetics, 1976
- Pharmacokinetics of digoxin in normal subjects after intravenous bolus and infusion dosesJournal of Pharmacokinetics and Biopharmaceutics, 1975
- Biological Availability of Digoxin from Lanoxin Produced in the United KingdomBMJ, 1973
- Pharmacokinetics of Digoxin: Interpreting BioavailabilityBMJ, 1973
- Curve fitting by spline and akima methods: possibility of interpolation error and its suppressionPhysics in Medicine & Biology, 1973
- An Overview of the Analysis and Interpretation of Bioavailability Studies in ManPharmacology, 1972
- Some Possible Errors in the Plotting and Interpretation of Semilogarithmic Plots of Blood Level and Urinary Excretion DataJournal of Pharmaceutical Sciences, 1963